1 jan 1962 ano - Kefauver-Harris Amendment of 1962
Descrição:
Expanded pre-market approval burden to include adequate proof that a drug is effective for its indicated use, not merely safe
Also added GMP requirement for manufacturers, violation of which amounts to adulteration
Adicionado na linha do tempo:
Data: